Sunobinop clinical trials
Also written V117957.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2013
How each study uses sunobinop is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
6 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2019 | 1 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Imbrium Therapeutics (3) · Knoa Pharma LLC (2) · Purdue Pharma LP (1)
Studies
Open first, then newest update. How each study uses sunobinop is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Study of Sunobinop on Craving in Alcohol Use DisorderCompletedPhase 2Knoa Pharma LLCNCT06545929Written as Sunobinop
- Study of Sunobinop on Alcohol Consumption in Alcohol Use DisorderCompletedPhase 2Knoa Pharma LLCNCT06545916Written as Sunobinop
- Study of V117957 in Interstitial Cystitis/Bladder Pain SyndromeCompletedPhase 1Imbrium TherapeuticsNCT06285214Written as V117957
- Study of V117957 in Overactive Bladder SyndromeCompletedPhase 1Imbrium TherapeuticsNCT06024642Written as V117957
- Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol CessationCompletedPhase 2Imbrium TherapeuticsNCT04035200Written as V117957 tablets
- An Analgesic Study to of V117957 for the Treatment of Postsurgical Pain Due to Third Molar ExtractionTerminatedPhase 2Purdue Pharma LPNCT01900795Written as V117957
Codes
What other systems call sunobinop · ClinicalTrials.gg INT016811
- UNII (FDA) I1X86U5474SUNOBINOPConfirmed FDA, Wikidata
- Wikidata Q111384063sunobinopConfirmed FDA, Wikidata
- NCI Thesaurus C179123SunobinopOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | I1X86U5474 | SUNOBINOP | Confirmed FDA, Wikidata |
| Wikidata | Q111384063 | sunobinop | Confirmed FDA, Wikidata |
| NCI Thesaurus | C179123 | Sunobinop | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.